BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 22415444)

  • 21. Sphingomyelin and sphingomyelin synthase (SMS) in the malignant transformation of glioma cells and in 2-hydroxyoleic acid therapy.
    Barceló-Coblijn G; Martin ML; de Almeida RF; Noguera-Salvà MA; Marcilla-Etxenike A; Guardiola-Serrano F; Lüth A; Kleuser B; Halver JE; Escribá PV
    Proc Natl Acad Sci U S A; 2011 Dec; 108(49):19569-74. PubMed ID: 22106271
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Differential effects of sphingomyelin hydrolysis and resynthesis on the activation of NF-kappa B in normal and SV40-transformed human fibroblasts.
    Luberto C; Yoo DS; Suidan HS; Bartoli GM; Hannun YA
    J Biol Chem; 2000 May; 275(19):14760-6. PubMed ID: 10799564
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Compound D609 inhibits phorbol ester-stimulated phospholipase D activity and phospholipase C-mediated phosphatidylethanolamine hydrolysis.
    Kiss Z; Tomono M
    Biochim Biophys Acta; 1995 Oct; 1259(1):105-8. PubMed ID: 7492608
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Role of sphingomyelin synthesis in pulmonary endothelial cell cytoskeletal activation and endotoxin-induced lung injury.
    Anjum F; Joshi K; Grinkina N; Gowda S; Cutaia M; Wadgaonkar R
    Am J Respir Cell Mol Biol; 2012 Jul; 47(1):94-103. PubMed ID: 22362386
    [TBL] [Abstract][Full Text] [Related]  

  • 25. D609-mediated inhibition of ATP synthesis in neural progenitor cells.
    Kalluri HS; Dempsey RJ
    Neuroreport; 2014 Jul; 25(10):777-81. PubMed ID: 24918458
    [TBL] [Abstract][Full Text] [Related]  

  • 26. D609, an inhibitor of phosphatidylcholine-specific phospholipase C, inhibits group IV cytosolic phospholipase A2.
    Kang MS; Jung SY; Jung KM; Kim SK; Ahn KH; Kim DK
    Mol Cells; 2008 Nov; 26(5):481-5. PubMed ID: 18688177
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Priming of alveolar macrophage respiratory burst by H(2)O(2) is prevented by phosphatidylcholine-specific phospholipase C inhibitor Tricyclodecan-9-yl-xanthate (D609).
    Girón-Calle J; Srivatsa K; Forman HJ
    J Pharmacol Exp Ther; 2002 Apr; 301(1):87-94. PubMed ID: 11907161
    [TBL] [Abstract][Full Text] [Related]  

  • 28. D609-phosphatidylcholine-specific phospholipase C inhibitor attenuates thapsigargin-induced sodium influx in human lymphocytes.
    Nofer JR; Junker R; Seedorf U; Assmann G; Zidek W; Tepel M
    Cell Signal; 2000 May; 12(5):289-96. PubMed ID: 10822169
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antidepressants act by inducing autophagy controlled by sphingomyelin-ceramide.
    Gulbins A; Schumacher F; Becker KA; Wilker B; Soddemann M; Boldrin F; Müller CP; Edwards MJ; Goodman M; Caldwell CC; Kleuser B; Kornhuber J; Szabo I; Gulbins E
    Mol Psychiatry; 2018 Dec; 23(12):2324-2346. PubMed ID: 30038230
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Stimulation of DNA synthesis in untransformed cells by the antiviral and antitumoral compound tricyclodecan-9-yl-xanthogenate (D609).
    Kiss Z; Crilly KS; Chung T
    Biochem Pharmacol; 1998 Mar; 55(6):915-8. PubMed ID: 9586966
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Human sphingomyelin synthase 1 generates diacylglycerol in the presence and absence of ceramide via multiple enzymatic activities.
    Suzuki R; Murakami C; Dilimulati K; Atsuta-Tsunoda K; Kawai T; Sakane F
    FEBS Lett; 2023 Nov; 597(21):2672-2686. PubMed ID: 37715942
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A novel role of the antitumor agent tricyclodecan-9-yl-xanthogenate as an open channel blocker of KCNQ1/KCNE1.
    Wu M; Takemoto M; Luo H; Xu JJ; Lu MH; Kameyama M; Takumi T; Song WJ
    Eur J Pharmacol; 2018 Apr; 824():99-107. PubMed ID: 29438706
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Phosphatidylcholine-specific phospholipase C (PC-PLC) is required for LPS-mediated macrophage activation through CD14.
    Cuschieri J; Billgren J; Maier RV
    J Leukoc Biol; 2006 Aug; 80(2):407-14. PubMed ID: 16754725
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Progesterone triggers the rapid activation of phospholipase D in the amphibian oocyte plasma membrane when initiating the G2/M transition.
    Kostellow AB; Ma GY; Morrill GA
    Biochim Biophys Acta; 1996 Dec; 1304(3):263-71. PubMed ID: 8982272
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Role of sphingomyelinase in mitochondrial ceramide accumulation during reperfusion.
    Ramírez-Camacho I; Bautista-Pérez R; Correa F; Buelna-Chontal M; Román-Anguiano NG; Medel-Franco M; Medina-Campos ON; Pedraza-Chaverri J; Cano-Martínez A; Zazueta C
    Biochim Biophys Acta; 2016 Oct; 1862(10):1955-63. PubMed ID: 27479697
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Phosphatidylcholine-specific phospholipase C and D in stimulation of RAW264.7 mouse macrophage-like cells by lipopolysaccharide.
    Zhang F; Zhao G; Dong Z
    Int Immunopharmacol; 2001 Jul; 1(7):1375-84. PubMed ID: 11460317
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Analysis of fluorescent ceramide and sphingomyelin analogs: a novel approach for in vivo monitoring of sphingomyelin synthase activity.
    Huang T; Li X; Hu S; Zhao B; Chen P; Liu X; Ye D; Cheng N
    Lipids; 2014 Oct; 49(10):1071-9. PubMed ID: 25108416
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Phosphatidylcholine-specific phospholipase C regulates activation of RAW264.7 macrophage-like cells by lipopeptide JBT3002.
    Zhang F; Zhao G; Dong Z
    J Leukoc Biol; 2001 Jun; 69(6):1060-6. PubMed ID: 11404395
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inhibition of PC-PLC blocked the survival of mouse neural cells by up-regulating the expression of integrin beta4 and Rb.
    Lv X; Wang N; Su L; Zhang S; Miao J
    Dev Neurosci; 2006; 28(6):499-504. PubMed ID: 17028427
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Daunorubicin- and mitoxantrone-triggered phosphatidylcholine hydrolysis: implication in drug-induced ceramide generation and apoptosis.
    Bettaïeb A; Plo I; Mansat-De Mas V; Quillet-Mary A; Levade T; Laurent G; Jaffrézou JP
    Mol Pharmacol; 1999 Jan; 55(1):118-25. PubMed ID: 9882705
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.